Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies - PubMed (original) (raw)
Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies
Y Kido et al. Pharm Res. 2000 Jan.
Abstract
Purpose: To prove the functional significance of monocarboxylic acid transporter, MCT1 at the blood-brain barrier (BBB) for the passage of both endogenous and exogenous monocarboxylic acids into the central nervous system.
Methods: Monocarboxylic acid transport at the BBB was studied in rats by using a newly established immortalized brain capillary endothelial cell (BCEC) line, RBEC1, and the results were compared with those obtained by using primary cultured BCECs, cells stably expressed with rat MCT1, and the in vivo brain uptake index (BUI) method.
Results: The cell line, RBEC1 meets various morphological and enzymatic criteria of BCECs and appears to be suitable for the study of BBB transport of monocarboxylic acids. The presence of MCT1-transcript in RBEC1 was confirmnned by the RT-PCR method, as previously observed in isolated brain capillaries. A typical substrate of MCT1, lactic acid, was taken up by RBEC1 in a stereospecific and saturable manner. The value of the kinetic parameter Km showed good agreement with values previously obtained in studies using an in vivo BUI and in vitro MCT1-transfected cells. An organic weak acid, benzoic acid, which has been considered to cross biological membranes by passive diffusion, exhibited carrier-mediated transport properties, such as saturation, pH dependence, and stereospecific inhibition in RBEC1, similar to those we observed in primary cultured rat BCECs. The Km values in RBEC1, in primary cultured BCECs and in the in vivo BUI method were comparable and well agreed with that obtained in MCT1-transfected cells, suggesting that the transport features of benzoic acid observed by in vitro methods well reflect the in vivo transport activity. Furthermore, hybrid depletion of MCT1 in RBEC1 using an antisense oligonucleotide against rat MCT1 abolished the saturable transport of benzoic acid.
Conclusions: These observations show that MCT1 plays a significant role in the transport of monocarboxylic acids, including the exogenous organic weak acid benzoic acid, as well as native lactic acid.
Similar articles
- Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1.
Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, Satoh E, Ogihara T, Amano O, Izeki S, Tsuji A. Tamai I, et al. J Pharm Pharmacol. 1999 Oct;51(10):1113-21. doi: 10.1211/0022357991776804. J Pharm Pharmacol. 1999. PMID: 10579682 - MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina.
Hosoya K, Kondo T, Tomi M, Takanaga H, Ohtsuki S, Terasaki T. Hosoya K, et al. Pharm Res. 2001 Dec;18(12):1669-76. doi: 10.1023/a:1013310210710. Pharm Res. 2001. PMID: 11785685 - Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.
Kido Y, Tamai I, Uchino H, Suzuki F, Sai Y, Tsuji A. Kido Y, et al. J Pharm Pharmacol. 2001 Apr;53(4):497-503. doi: 10.1211/0022357011775794. J Pharm Pharmacol. 2001. PMID: 11341366 - Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.
Roux F, Couraud PO. Roux F, et al. Cell Mol Neurobiol. 2005 Feb;25(1):41-58. doi: 10.1007/s10571-004-1376-9. Cell Mol Neurobiol. 2005. PMID: 15962508 Free PMC article. Review. - Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport.
Edmond J. Edmond J. J Mol Neurosci. 2001 Apr-Jun;16(2-3):181-93; discussion 215-21. doi: 10.1385/JMN:16:2-3:181. J Mol Neurosci. 2001. PMID: 11478373 Review.
Cited by
- Effects of Cadmium on ZO-1 Tight Junction Integrity of the Blood Brain Barrier.
Branca JJV, Maresca M, Morucci G, Mello T, Becatti M, Pazzagli L, Colzi I, Gonnelli C, Carrino D, Paternostro F, Nicoletti C, Ghelardini C, Gulisano M, Di Cesare Mannelli L, Pacini A. Branca JJV, et al. Int J Mol Sci. 2019 Nov 29;20(23):6010. doi: 10.3390/ijms20236010. Int J Mol Sci. 2019. PMID: 31795317 Free PMC article. - Stroke-induced damage on the blood-brain barrier.
Xue S, Zhou X, Yang ZH, Si XK, Sun X. Xue S, et al. Front Neurol. 2023 Sep 28;14:1248970. doi: 10.3389/fneur.2023.1248970. eCollection 2023. Front Neurol. 2023. PMID: 37840921 Free PMC article. Review. - Ion and water permeation through claudin-10b and claudin-15 paracellular channels.
Berselli A, Alberini G, Benfenati F, Maragliano L. Berselli A, et al. Comput Struct Biotechnol J. 2024 Nov 13;23:4177-4191. doi: 10.1016/j.csbj.2024.11.025. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39640531 Free PMC article. - Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.
Tsuji A. Tsuji A. NeuroRx. 2005 Jan;2(1):54-62. doi: 10.1602/neurorx.2.1.54. NeuroRx. 2005. PMID: 15717057 Free PMC article. Review. - Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S, Arzua T, Canfield SG, Seminary ER, Sison SL, Ebert AD, Bai X. Logan S, et al. Compr Physiol. 2019 Mar 14;9(2):565-611. doi: 10.1002/cphy.c180025. Compr Physiol. 2019. PMID: 30873582 Free PMC article. Review.
References
- J Pharmacobiodyn. 1990 Feb;13(2):158-63 - PubMed
- J Pharmacol Exp Ther. 1998 Jun;285(3):1175-80 - PubMed
- Biochem J. 1998 Jan 15;329 ( Pt 2):321-8 - PubMed
- J Pharm Pharmacol. 1999 Oct;51(10):1113-21 - PubMed
- Brain Res Mol Brain Res. 1998 Jul 15;58(1-2):178-87 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources